Efficacy and safety of sitagliptin added to ongoing metformin and pioglitazone combination therapy in a randomized, placebo-controlled, 26-week trial in patients with type 2 diabetes (Q43467002)
Jump to navigation
Jump to search
scientific article published on 30 October 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of sitagliptin added to ongoing metformin and pioglitazone combination therapy in a randomized, placebo-controlled, 26-week trial in patients with type 2 diabetes |
scientific article published on 30 October 2012 |
Statements
1 reference
Efficacy and safety of sitagliptin added to ongoing metformin and pioglitazone combination therapy in a randomized, placebo-controlled, 26-week trial in patients with type 2 diabetes (English)
1 reference
1 reference
Vivian Fonseca
1 reference
Jerry D Morgan
1 reference
Yue Shentu
1 reference
Gregory T Golm
1 reference
Amy O Johnson-Levonas
1 reference
Keith D Kaufman
1 reference
Barry J Goldstein
1 reference
Helmut Steinberg
1 reference
30 October 2012
1 reference
1 reference
Identifiers
1 reference